The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment

The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment

Abstract Background Metabolic pathways are known to significantly impact the development and advancement of lung cancer. This study sought to establish a signature related to butyrate metabolism that is specifically linked to lung adenocarcinoma (LUAD). Methods For the purpose of identifying butyrat...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanchao Luan, Chao Liang, Qingsong Han, Xueqin Zhou, Na Yang, li Zhao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Lung adenocarcinoma
Butyrate metabolism
Prognostic signature
Risk subgroups
CDKN3
Online Access:https://doi.org/10.1186/s12885-024-13409-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13409-w

Similar Items